XML 79 R54.htm IDEA: XBRL DOCUMENT v3.25.0.1

SEGMENT INFORMATION (Tables)

12 Months Ended

Dec. 31, 2024

Segment Reporting [Abstract]

Schedule of Information About Reportable Segments and Reconciliation of Segment Net Sales and Pre-Tax Income

The table below presents information about Edwards Lifesciences' reportable segments (in millions):

			Years Ended December 31,
			2024						2023						2022
Segment Net Sales
United States			$	3,206.0					$	2,947.9					$	2,628.2
Europe			1,321.7						1,180.2						1,040.3
Japan			339.8						350.8						359.5
Rest of World			572.0						531.1						436.0
Total segment net sales			$	5,439.5					$	5,010.0					$	4,464.0
Cost of Sales
United States			$	546.6					$	505.2					$	418.9
Europe			299.1						268.5						237.9
Japan			48.1						46.6						41.5
Rest of World			158.1						136.2						118.2
Total segment cost of sales			$	1,051.9					$	956.5					$	816.5
Selling, general, and administrative expenses
United States			$	498.0					$	432.8					$	340.7
Europe			282.6						260.6						233.0
Japan			85.1						70.1						77.4
Rest of World			181.4						166.4						142.6
Total segment selling, general, and administrative expenses			$	1,047.1					$	929.9					$	793.7
Other Segment Items
United States			$	2.4					$	2.1					$	4.8
Europe			14.9						(4.0)						(34.9)
Japan			(6.8)						21.3						(58.1)
Rest of World			(10.5)						(0.5)						(1.9)
Total other segment items (a)			$	—					$	18.9					$	(90.1)
Segment Operating Income
United States			$	2,159.0					$	2,007.8					$	1,863.8
Europe			725.1						655.1						604.3
Japan			213.4						212.8						298.7
Rest of World			243.0						229.0						177.1
Total segment operating income			$	3,340.5					$	3,104.7					$	2,943.9

_______________________________________________________________________________

(a)    Other segment items include research and development expenses and foreign currency.

			Years Ended December 31,
			2024						2023						2022
Pre-tax Income Reconciliation
Segment operating income			$	3,340.5					$	3,104.7					$	2,943.9
Unallocated amounts:
Corporate items			(1,886.8)						(1,684.4)						(1,504.2)
Restructuring charges, separation costs, and other			(61.0)						—						(60.7)
Intellectual property agreement and certain litigation expenses			(40.4)						(203.5)						(15.8)
Change in fair value of contingent consideration liabilities			—						26.2						35.8
Foreign currency			26.4						65.9						99.4
Consolidated operating income			$	1,378.7					$	1,308.9					$	1,498.4
Non-operating income			169.4						63.5						21.1
Consolidated pre-tax income			$	1,548.1					$	1,372.4					$	1,519.5

Schedule of Enterprise-Wide Information

Enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated financial statements. Refer to the segment information above for United States net sales for the years ended December 31, 2024, 2023, and 2022. Sales within any other individual country were less than 10 percent of the Company's consolidated net sales in each of those years.

			As of or for the Years Ended December 31,
			2024						2023						2022
Net Sales by Major Product Group
Transcatheter Aortic Valve Replacement			$	4,106.1					$	3,879.8					$	3,518.2
Transcatheter Mitral and Tricuspid Therapies			352.1						197.6						116.1
Surgical Structural Heart			981.3						932.6						829.7
			$	5,439.5					$	5,010.0					$	4,464.0
Long-lived Tangible Assets by Geographic Region
United States			$	1,249.6					$	1,186.9					$	1,113.3
Other countries			534.6						488.5						457.0
			$	1,784.2					$	1,675.4					$	1,570.3

X

- Definition

Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

+ Details

Name:	us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration